most patients at risk for adverse effects during beta blockade ( i.e. , those with diabetes mellitus , congestive heart failure , asthma , etc . ) tolerated esmolol therapy , and there were no clinically important trends among the reported changes in laboratory variables .
C0018802
congestive heart failure
C0116569
therapy